Sunlovis Pharmaceuticals Llp Profile
Key Indicators
- Obligation of Contribution ₹ 0.10 M
as on 26-07-2024
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 16.27 Cr
as on 26-07-2024
- Revenue 35.30%
(FY 2021)
- Profit -26.84%
(FY 2021)
- Ebitda 28.57%
(FY 2021)
- Total Assets -5.16%
(FY 2021)
About Sunlovis Pharmaceuticals Llp
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 0.10 M as per MCA.
- CIN/LLPIN/FCRN
AAI-8723
- Incorporation Date
20 Mar 2017
- Date of Accounts and Solvency Statement
31 Mar 2023
- ROC Code
Roc-Ahmedabad
- Company Classification
Limited Liability Partnership
Industry
Company Details
- Location
Gandhi Nagar, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Sunlovis Pharmaceuticals Llp?
Designated Partners(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pravinkumar Chaudhary  | Designated Partner | 11-May-2021 | Current |
| Pravinbhai Chaudhari | Designated Partner | 20-Mar-2017 | Current |
| Vipulkumar Chaudhari | Designated Partner | 20-Mar-2017 | Current |
| Babulal Chaudhary | Designated Partner | 20-Mar-2017 | Current |
| Vijaykumar Chaudhari | Designated Partner | 20-Mar-2017 | Current |
| Yogesh Chaudhary | Designated Partner | 20-Mar-2017 | Current |
Financial Performance of Sunlovis Pharmaceuticals Llp.
Sunlovis Pharmaceuticals Llp, for the financial year ended 2021, experienced significant growth in revenue, with a 35.3% increase. The company also saw a substantial fall in profitability, with a 26.84% decrease in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sunlovis Pharmaceuticals Llp?
Unlock access to Sunlovis Pharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Hagios Life Sciences Private LimitedActive 13 years 14 daysPravinkumar Chaudhary is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Au Small Finance Bank Limited Creation Date: 31 Mar 2022 | ₹1.20 Cr | Open |
Au Small Finance Bank Limited Creation Date: 12 Jan 2022 | ₹10.07 Cr | Open |
The Mehsana Urban Co-Operative Bank Limited Creation Date: 25 Sep 2018 | ₹5.00 Cr | Open |
How Many Employees Work at Sunlovis Pharmaceuticals Llp?
Sunlovis Pharmaceuticals Llp has a workforce of 34 employees as of Jul 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sunlovis Pharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sunlovis Pharmaceuticals Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
